Kintu K, Malaba T, Nakibuka J, et al. RCT of Dolutegravir vs Efavirenz-based therapy initiated in late pregnancy: DOLPHIN-2. CROI 2019, abstract 40-LB.
Off-target antilichaamrespons malariavaccin leidt tot brede bescherming
jun 2022 | Parasitaire infecties, Vaccinatie